CRDFCardiff Oncology, Inc.

Nasdaq cardiffoncology.com


$ 3.60 $ -0.57 (-13.67 %)    

Friday, 03-May-2024 15:38:07 EDT
QQQ $ 435.70 $ 3.38 (0.78 %)
DIA $ 386.77 $ 0.03 (0.01 %)
SPY $ 511.64 $ 1.11 (0.22 %)
TLT $ 89.78 $ -0.33 (-0.37 %)
GLD $ 212.77 $ -0.67 (-0.31 %)
$ 4.48
$ 4.17
$ 0.00 x 0
$ 3.63 x 200
$ 3.12 - $ 4.24
$ 0.94 - $ 6.42
843,863
na
200.16M
$ 1.50
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-02-2024 03-31-2024 10-Q
2 02-29-2024 12-31-2023 10-K
3 11-02-2023 09-30-2023 10-Q
4 08-09-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 03-02-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 02-24-2022 12-31-2021 10-K
11 11-04-2021 09-30-2021 10-Q
12 08-05-2021 06-30-2021 10-Q
13 05-06-2021 03-31-2021 10-Q
14 02-25-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 08-11-2020 06-30-2020 10-Q
17 05-07-2020 03-31-2020 10-Q
18 02-27-2020 12-31-2019 10-K
19 11-07-2019 09-30-2019 10-Q
20 08-08-2019 06-30-2019 10-Q
21 05-07-2019 03-31-2019 10-Q
22 03-06-2019 12-31-2018 10-K
23 11-07-2018 09-30-2018 10-Q
24 08-03-2018 06-30-2018 10-Q
25 05-08-2018 03-31-2018 10-Q
26 02-26-2018 12-31-2017 10-K
27 11-09-2017 09-30-2017 10-Q
28 08-09-2017 06-30-2017 10-Q
29 05-10-2017 03-31-2017 10-Q
30 03-15-2017 12-31-2016 10-K
31 11-09-2016 09-30-2016 10-Q
32 08-04-2016 06-30-2016 10-Q
33 05-10-2016 03-31-2016 10-Q
34 03-10-2016 12-31-2015 10-K
35 11-09-2015 09-30-2015 10-Q
36 08-10-2015 06-30-2015 10-Q
37 05-05-2015 03-31-2015 10-Q
38 03-12-2015 12-31-2014 10-K
39 11-06-2014 09-30-2014 10-Q
40 08-07-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cardiff-oncology-q1-2024-gaap-eps-022-beats-025-estimate-sales-205000k-beat-55000k-estimate

Cardiff Oncology (NASDAQ:CRDF) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0....

 cardiff-oncology-presents-novel-preclinical-data-at-aacr-annual-meeting-2024-supports-first-line-ras-mutated-mcrc-clinical-study

– In RAS-mutated mCRC, novel preclinical finding demonstrates onvansertib inhibits the tumor's ability to adapt to hypoxia ...

 hc-wainwright--co-maintains-buy-on-cardiff-oncology-raises-price-target-to-14

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Cardiff Oncology (NASDAQ:CRDF) with a Buy and raises the price ...

 crude-oil-down-over-1-quoin-pharmaceuticals-shares-spike-higher

U.S. stocks traded lower toward the end of trading, with the S&P 500 edging lower on Monday. The Dow traded down 0.20% to ...

 why-bitdeer-technologies-shares-are-trading-higher-by-10-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Bitdeer Technologies Group (NASDAQ: BTDR) rose sharply during Monday’s session after the company reported prelimina...

 crude-oil-rises-over-2-fisker-shares-plummet

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 1% on Friday. The Dow traded ...

 why-zscaler-shares-are-trading-lower-by-10-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of Zscaler, Inc. (NASDAQ: ZS) shares fell sharply during Friday’s session following second-quarter results.

 nasdaq-surges-100-points-ism-manufacturing-pmi-falls-in-february

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 100 points on Friday. The Dow trade...

 small-cap-cardiff-oncology-outlines-data-from-discontinued-colorectal-cancer-trial-stock-soars

Cardiff Oncology's clinical update on ONSEMBLE trial data for onvansertib in second-line RAS-mutated metastatic colorectal ...

 piper-sandler-maintains-overweight-on-cardiff-oncology-raises-price-target-to-7

Piper Sandler analyst Joseph Catanzaro maintains Cardiff Oncology (NASDAQ:CRDF) with a Overweight and raises the price targe...

 why-netapp-shares-are-trading-higher-by-around-17-here-are-20-stocks-moving-premarket

Shares of NetApp, Inc. (NASDAQ: NTAP) shares rose sharply in today’s pre-market trading after the company reported better-than...

 cardiff-oncology-q4-2023-gaap-eps-0210-beats-0280-estimate-sales-156000k-beat-37500k-estimate

Cardiff Oncology (NASDAQ:CRDF) reported quarterly losses of $(0.210) per share which beat the analyst consensus estimate of $(0...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION